AFP and cancer: In addition, there was no significant difference among patients with different types of cancer (χ2 = 2.886, P = .410), and TAP expression was shown to be correlated with AFP in liver cancer (P = .034) but not with CA19-9 in pancreatic cancer (P = .241).